Skip to main content

Publications searcher

The science produced by our scientists is very important. In 2024, 1,501 papers were published in scientific journals with an average impact factor of over 7.13 points.

Efficacy and safety of tiotropium and olodaterol in COPD: a systematic review and meta-analysis.

PMID: 29178871
Journal: RESPIRATORY RESEARCH
Year: 2017
Reference: Respir Res. 2017 Nov 25;18(1):196. doi: 10.1186/s12931-017-0683-x.
Impact factor: 3.841
Publication type: Paper in international publication
Authors: Miravitlles, Marc, Urrutia, Gerard, Mathioudakis, Alexander G, Ancochea, Julio et al.
DOI: 10.1186/s12931-017-0683-x

Efficacy and safety of tiotropium and olodaterol in COPD: a systematic review and meta-analysis.

PMID: 29178871
Journal: RESPIRATORY RESEARCH
Year: 2017
Reference: Respir Res. 2017 Nov 25;18(1):196. doi: 10.1186/s12931-017-0683-x.
Impact factor:
Publication type: Paper in international publication
Authors: Ancochea, Julio; Mathioudakis, Alexander G; Miravitlles, Marc; Urrutia, Gerard et al.
DOI: 10.1186/s12931-017-0683-x

Efficacy and tolerability of interferon-free antiviral therapy in kidney transplant recipients with chronic hepatitis c.

PMID: 28039098
Journal: JOURNAL OF HEPATOLOGY
Year: 2017
Reference: J Hepatol. 2017 Apr;66(4):718-723. doi: 10.1016/j.jhep.2016.12.020. Epub 2016 Dec 28.
Impact factor: 10.59
Publication type: Paper in international publication
Authors: Forns, Xavier, Londono, Maria-Carlota, Calleja, Jose L, Crespo, Javier, Cuervas-Mons, Valentin, Fernandez, Inmaculada, Munoz-Gomez, Raquel, Pascasio, Juan M, Baliellas, Carme, Polanco, Natalia et al.
DOI: 10.1016/j.jhep.2016.12.020

Efficacy and tolerability of interferon-free antiviral therapy in kidney transplant recipients with chronic hepatitis c.

PMID: 28039098
Journal: JOURNAL OF HEPATOLOGY
Year: 2017
Reference: J Hepatol. 2017 Apr;66(4):718-723. doi: 10.1016/j.jhep.2016.12.020. Epub 2016 Dec 28.
Impact factor:
Publication type: Paper in international publication
Authors: Arias, Ana; Baliellas, Carme; Calleja, Jose L; Castells, Lluis; Crespo, Javier; Cuervas-Mons, Valentin; Esforzado, Nuria; Fernandez, Inmaculada; Forns, Xavier; Hernandez, Olga et al.
DOI: 10.1016/j.jhep.2016.12.020

Efficacy of a 12-Week Simeprevir Plus Peginterferon/Ribavirin (PR) Regimen in Treatment-Naive Patients with Hepatitis C Virus (HCV) Genotype 4 (GT4) Infection and Mild-To-Moderate Fibrosis Displaying Early On-Treatment Virologic Response.

PMID: 28056030
Journal: PLoS One
Year: 2017
Reference: PLoS One. 2017 Jan 5;12(1):e0168713. doi: 10.1371/journal.pone.0168713. eCollection 2017.
Impact factor: 2.806
Publication type: Paper in international publication
Authors: Craxi, Antonio, Asselah, Tarik, Moreno, Christophe, Sarrazin, Christoph, Gschwantler, Michael, Foster, Graham R, Bicer, Ceyhun, Lenz, Oliver, Van Dooren, Gino, Nalpas, Catherine et al.
DOI: 10.1371/journal.pone.0168713

Efficacy of a 12-Week Simeprevir Plus Peginterferon/Ribavirin (PR) Regimen in Treatment-Naive Patients with Hepatitis C Virus (HCV) Genotype 4 (GT4) Infection and Mild-To-Moderate Fibrosis Displaying Early On-Treatment Virologic Response.

PMID: 28056030
Journal: PLoS One
Year: 2017
Reference: PLoS One. 2017 Jan 5;12(1):e0168713. doi: 10.1371/journal.pone.0168713. eCollection 2017.
Impact factor:
Publication type: Paper in international publication
Authors: Asselah, Tarik; Bicer, Ceyhun; Buggisch, Peter; Buti, Maria; Craxi, Antonio; Foster, Graham R; Gschwantler, Michael; Lenz, Oliver; Lonjon-Domanec, Isabelle; Moreno, Christophe et al.
DOI: 10.1371/journal.pone.0168713

Efficacy of beta-lactam/beta-lactamase inhibitor combinations for the treatment of bloodstream infection due to extended-spectrum beta-lactamase-producing Enterobacteriaceae in hematological patients with neutropenia.

PMID: 28584145
Journal: ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Year: 2017
Reference: Antimicrob Agents Chemother. 2017 Jul 25;61(8). pii: e00164-17. doi: 10.1128/AAC.00164-17. Print 2017 Aug.
Impact factor: 4.302
Publication type: Paper in international publication
Authors: Abdala, Edson, Akova, Murat, Alvarez, Rocio, Maestro-de la Calle, Guillermo, Cano, Angela, Cervera, Carlos, Clemente, Wanessa T, Martin-Davila, Pilar, Freifeld, Alison, Gomez, Lucia et al.
DOI: 10.1128/AAC.00164-17

Efficacy of beta-lactam/beta-lactamase inhibitor combinations for the treatment of bloodstream infection due to extended-spectrum beta-lactamase-producing Enterobacteriaceae in hematological patients with neutropenia.

PMID: 28584145
Journal: ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Year: 2017
Reference: Antimicrob Agents Chemother. 2017 Jul 25;61(8). pii: e00164-17. doi: 10.1128/AAC.00164-17. Print 2017 Aug.
Impact factor:
Publication type: Paper in international publication
Authors: Abdala, Edson; Akova, Murat; Alvarez, Rocio; Cano, Angela; Carratala, Jordi; Cervera, Carlos; Clemente, Wanessa T; Freifeld, Alison; Gomez, Lucia; Gottlieb, Thomas et al.
DOI: 10.1128/AAC.00164-17

Efficacy of immunomodulatory therapy with interferon-beta or glatiramer acetate on multiple sclerosis-associated uveitis.

PMID: 28188020
Journal: Archivos de la Sociedad Espanola de Oftalmologia
Year: 2017
Reference: Arch Soc Esp Oftalmol. 2017 Jun;92(6):273-279. doi: 10.1016/j.oftal.2016.11.018. Epub 2017 Feb 8.
Impact factor: 0
Publication type: Paper in national publication
Authors: Velazquez-Villoria, D, Macia-Badia, C, Segura-Garcia, A, Pastor Idoate, S, Arcos-Algaba, G, Velez-Escola, L, Garcia-Arumi, J et al.
DOI: 10.1016/j.oftal.2016.11.018

Efficacy of immunomodulatory therapy with interferon-beta or glatiramer acetate on multiple sclerosis-associated uveitis.

PMID: 28188020
Journal: Archivos de la Sociedad Espanola de Oftalmologia
Year: 2017
Reference: Arch Soc Esp Oftalmol. 2017 Jun;92(6):273-279. doi: 10.1016/j.oftal.2016.11.018. Epub 2017 Feb 8.
Impact factor:
Publication type: Paper in national publication
Authors: Arcos-Algaba, G; Garcia-Arumi, J; Macia-Badia, C; Pastor Idoate, S; Segura-Garcia, A; Velazquez-Villoria, D; Velez-Escola, L et al.
DOI: 10.1016/j.oftal.2016.11.018

Efficacy of laronidase therapy in patients with mucopolysaccharidosis type I who initiated enzyme replacement therapy in adult age. A systematic review and meta-analysis.

PMID: 28410878
Journal: MOLECULAR GENETICS AND METABOLISM
Year: 2017
Reference: Mol Genet Metab. 2017 Jun;121(2):138-149. doi: 10.1016/j.ymgme.2017.04.004. Epub 2017 Apr 9.
Impact factor: 3.769
Publication type: Paper in international publication
Authors: Perez-Lopez, Jordi, Morales-Conejo, Montserrat, Lopez-Rodriguez, Monica, Hermida-Ameijeiras, Alvaro, Molto-Abad, Marc et al.
DOI: 10.1016/j.ymgme.2017.04.004

Efficacy of laronidase therapy in patients with mucopolysaccharidosis type I who initiated enzyme replacement therapy in adult age. A systematic review and meta-analysis.

PMID: 28410878
Journal: MOLECULAR GENETICS AND METABOLISM
Year: 2017
Reference: Mol Genet Metab. 2017 Jun;121(2):138-149. doi: 10.1016/j.ymgme.2017.04.004. Epub 2017 Apr 9.
Impact factor:
Publication type: Paper in international publication
Authors: Hermida-Ameijeiras, Alvaro; Lopez-Rodriguez, Monica; Molto-Abad, Marc; Morales-Conejo, Montserrat; Perez-Lopez, Jordi et al.
DOI: 10.1016/j.ymgme.2017.04.004

Efficacy of loading dose of colistin in Acinetobacter baumannii ventilator-associated pneumonia.

PMID: 29286009
Journal: Le infezioni in medicina : rivista periodica di ez
Year: 2017
Reference: Infez Med. 2017 Dec 1;25(4):311-319.
Impact factor: 0
Publication type: Paper in international publication
Authors: Rello, Jordi, Alp, Emine, Eren, Esma, Elay, Gulseren, Cevahir, Fatma, Esmaoglu, Aliye et al.
DOI:

Efficacy of loading dose of colistin in Acinetobacter baumannii ventilator-associated pneumonia.

PMID: 29286009
Journal: Le infezioni in medicina : rivista periodica di ez
Year: 2017
Reference: Infez Med. 2017 Dec 1;25(4):311-319.
Impact factor:
Publication type: Paper in international publication
Authors: Alp, Emine; Cevahir, Fatma; Elay, Gulseren; Eren, Esma; Esmaoglu, Aliye; Rello, Jordi et al.
DOI:

Efficacy of neoadjuvant carboplatin plus docetaxel in triple negative breast cancer: Combined analysis of two cohorts.

PMID: 27301700
Journal: CLINICAL CANCER RESEARCH
Year: 2017
Reference: Clin Cancer Res. 2017 Feb 1;23(3):649-657. doi: 10.1158/1078-0432.CCR-16-0162. Epub 2016 Jun 14.
Impact factor: 8.738
Publication type: Paper in international publication
Authors: Lopez-Tarruella, Sara, Garcia-Saenz, Jose Angel, Ward, Claire, Connor, Carol, Gomez, Henry L, Prat, Aleix, Moreno, Fernando, Jerez-Gilarranz, Yolanda, Barnadas, Agusti, Picornell, Antoni et al.
DOI: 10.1158/1078-0432.CCR-16-0162

Efficacy of neoadjuvant carboplatin plus docetaxel in triple negative breast cancer: Combined analysis of two cohorts.

PMID: 27301700
Journal: CLINICAL CANCER RESEARCH
Year: 2017
Reference: Clin Cancer Res. 2017 Feb 1;23(3):649-657. doi: 10.1158/1078-0432.CCR-16-0162. Epub 2016 Jun 14.
Impact factor:
Publication type: Paper in international publication
Authors: Amin, Amanda; Barnadas, Agusti; Bretel Morales, Denisse; Connor, Carol; Cortes, Javier; Del Monte-Millan, Maria; Fabian, Carol J; Fuentes Rivera, Hugo; Garcia-Saenz, Jose Angel; Godwin, Andrew K et al.
DOI: 10.1158/1078-0432.CCR-16-0162

Efficacy of trifluridine and tipiracil (TAS-102) versus placebo, with supportive care, in a randomized, controlled trial of patients with metastatic colorectal cancer from Spain: results of a subgroup analysis of the phase 3 RECOURSE trial.

PMID: 27443414
Journal: Clinical & Translational Oncology
Year: 2017
Reference: Clin Transl Oncol. 2017 Feb;19(2):227-235. doi: 10.1007/s12094-016-1528-7. Epub 2016 Jul 21.
Impact factor: 2.353
Publication type: Paper in international publication
Authors: Longo-Munoz, F, Argiles, G, Tabernero, J, Cervantes, A, Gravalos, C, Pericay, C, Gil-Calle, S, Mizuguchi, H, Carrato-Mena, A, Limon, M L et al.
DOI: 10.1007/s12094-016-1528-7

Efficacy of trifluridine and tipiracil (TAS-102) versus placebo, with supportive care, in a randomized, controlled trial of patients with metastatic colorectal cancer from Spain: results of a subgroup analysis of the phase 3 RECOURSE trial.

PMID: 27443414
Journal: Clinical & Translational Oncology
Year: 2017
Reference: Clin Transl Oncol. 2017 Feb;19(2):227-235. doi: 10.1007/s12094-016-1528-7. Epub 2016 Jul 21.
Impact factor:
Publication type: Paper in international publication
Authors: Argiles, G; Carrato-Mena, A; Cervantes, A; Garcia-Carbonero, R; Gil-Calle, S; Gravalos, C; Limon, M L; Longo-Munoz, F; Mizuguchi, H; Pericay, C et al.
DOI: 10.1007/s12094-016-1528-7

Efficacy of tyrosine kinase inhibitors in EGFR-mutant lung cancer women in a real-world setting: the WORLD07 database.

PMID: 28660482
Journal: Clinical & Translational Oncology
Year: 2017
Reference: Clin Transl Oncol. 2017 Dec;19(12):1537-1542. doi: 10.1007/s12094-017-1700-8. Epub 2017 Jun 28.
Impact factor: 2.353
Publication type: Paper in international publication
Authors: de Castro, J, Remon, J, Isla, D, Garrido, P, Artal, A, Carcereny, E, Garcia-Campelo, M R, Lianes, P, Provencio, M, Juan, O et al.
DOI: 10.1007/s12094-017-1700-8

Efficacy of tyrosine kinase inhibitors in EGFR-mutant lung cancer women in a real-world setting: the WORLD07 database.

PMID: 28660482
Journal: Clinical & Translational Oncology
Year: 2017
Reference: Clin Transl Oncol. 2017 Dec;19(12):1537-1542. doi: 10.1007/s12094-017-1700-8. Epub 2017 Jun 28.
Impact factor:
Publication type: Paper in international publication
Authors: Artal, A; Blanco, R; Carcereny, E; de Castro, J; Diz, P; Felip, E; Garcia-Campelo, M R; Garrido, P; Isla, D; Juan, O et al.
DOI: 10.1007/s12094-017-1700-8

Efficacy, safety, and tolerability of lacosamide monotherapy versus controlled-release carbamazepine in patients with newly diagnosed epilepsy: a phase 3, randomised, double-blind, non-inferiority trial.

PMID: 27889312
Journal: LANCET NEUROLOGY
Year: 2017
Reference: Lancet Neurol. 2017 Jan;16(1):43-54. doi: 10.1016/S1474-4422(16)30292-7. Epub 2016 Nov 24.
Impact factor: 26.284
Publication type: Clinical Trials
Authors: Baulac, Michel, Rosenow, Felix, Toledo, Manuel, Terada, Kiyohito, Li, Ting, De Backer, Marc, Werhahn, Konrad J, Brock, Melissa et al.
DOI: 10.1016/S1474-4422(16)30292-7

Efficacy, safety, and tolerability of lacosamide monotherapy versus controlled-release carbamazepine in patients with newly diagnosed epilepsy: a phase 3, randomised, double-blind, non-inferiority trial.

PMID: 27889312
Journal: LANCET NEUROLOGY
Year: 2017
Reference: Lancet Neurol. 2017 Jan;16(1):43-54. doi: 10.1016/S1474-4422(16)30292-7. Epub 2016 Nov 24.
Impact factor:
Publication type: Clinical Trials
Authors: Baulac, Michel; Brock, Melissa; De Backer, Marc; Li, Ting; Rosenow, Felix; Terada, Kiyohito; Toledo, Manuel; Werhahn, Konrad J et al.
DOI: 10.1016/S1474-4422(16)30292-7

Electrochemical lateral flow devices: towards rapid immunomagnetic-assays

PMID: NOPMID001
Journal: ChemElectroChem
Year: 2017
Reference:
Impact factor: 4.136
Publication type: Paper in international publication
Authors: Ruiz-Vega, Gisela, Kitsara, Maria, Aller Pellitero, Miguel, Baldrich Rubio, Eva, del Campo, F. Javier et al.
DOI: 10.1002/celc.201600902

Electrochemical lateral flow devices: towards rapid immunomagnetic-assays

PMID: NOPMID001
Journal: ChemElectroChem
Year: 2017
Reference:
Impact factor:
Publication type: Paper in international publication
Authors: Aller Pellitero, Miguel; Baldrich Rubio, Eva; del Campo, F. Javier; Kitsara, Maria; Ruiz-Vega, Gisela et al.
DOI: 10.1002/celc.201600902